BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7511273)

  • 1. [Incidence and morphology of coexisting carcinomas of the urinary bladder and prostate].
    Weidhase A; Kunze E
    Verh Dtsch Ges Pathol; 1993; 77():142-6. PubMed ID: 7511273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and morphology of concurrent primary carcinomas of the urinary bladder and prostate in transurethral resection specimens.
    Kunze E; Weidhase A; Schulz H
    Zentralbl Pathol; 1994 Jul; 140(2):113-22. PubMed ID: 7947617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous primary carcinomas of the bladder and prostate.
    Lee SH; Chang PL; Chen SM; Sun GH; Chen CL; Shen BY; Wu YS; Tsui KH
    Asian J Androl; 2006 May; 8(3):357-9. PubMed ID: 16625287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial carcinoma of the prostate.
    Goebbels R; Amberger L; Wernert N; Dhom G
    Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of prostatic cancer.
    Hohbach C; Dhom G
    Scand J Urol Nephrol Suppl; 1980; 55():37-47. PubMed ID: 6938034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated tissue eosinophilia in the urinary bladder: is it a real relationship?
    Dworák O; Janssen D
    Appl Pathol; 1989; 7(5):294-7. PubMed ID: 2635616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic tumors in Iran.
    Habibi A; Manouchehri A; Diba MH; Sajadi M; Ghavam M
    Int Surg; 1975 Aug; 60(8):405-7. PubMed ID: 1158617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].
    Takada T; Honda M; Momohara C; Komori K; Fujioka H
    Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.
    Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A
    Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
    Lerner SP; Shen S
    Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
    Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
    Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostatic urothelial location of a tumor of the bladder].
    Coulange C; Lechevallier E; de Fromont M
    Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transitional cell carcinoma involvement of the prostate].
    Bassi P; De Lisa A; Usai P; Pinto F; Sacco E
    Ann Urol (Paris); 2005 Nov; 39 Suppl 5():S113-9. PubMed ID: 16425728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.